Winnie H Wan

Winnie H Wan has a long and varied work experience. Winnie H began their career as the CEO and Founder of BEING BioPharma in 2008. In 2009, they became the Executive Chairman and CEO of OncoHealth Corp. and in 2015 they took on the role of Board Director and Advisor at Nanotech Biomachines, Inc. In 2017, they became a Board Director at Bell Biosystems, Inc. and also began their role as a Miller Center GSBI Lead Mentor at Santa Clara University. In 2018, they were a Board Director at Life Science Angels and Board Director and Executive Advisor at Inhalon Biopharma, Inc. Winnie H currently holds the roles of Board Director and Executive Advisor at Chameleon Biosciences, Inc. and Kryptos Biotechnolgies, Inc., and Board Director and Executive Advisor at Saccharo Inc.

Winnie H Wan holds a PhD in Biochemistry from Yale University, a BA in Chemistry from Skidmore College, and an MBA in Business Management from Columbia Business School.